REGIONAL HEALTH PROPERTIES (RHE) Fundamental Analysis & Valuation
NYSEARCA:RHE • US75903M3097
Current stock price
2.7741 USD
+0.09 (+3.51%)
Last:
This RHE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. RHE Profitability Analysis
1.1 Basic Checks
- RHE had negative earnings in the past year.
- In the past year RHE had a positive cash flow from operations.
- RHE had negative earnings in 4 of the past 5 years.
- Of the past 5 years RHE 4 years had a positive operating cash flow.
1.2 Ratios
- RHE has a Return On Assets of -4.81%. This is in the lower half of the industry: RHE underperforms 62.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.81% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)10.26%
ROA(5y)3.75%
ROE(3y)6943.44%
ROE(5y)4142.66%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- RHE's Gross Margin of 49.69% is fine compared to the rest of the industry. RHE outperforms 76.85% of its industry peers.
- The Profit Margin and Operating Margin are not available for RHE so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 49.69% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. RHE Health Analysis
2.1 Basic Checks
- RHE does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, RHE has more shares outstanding
- Compared to 1 year ago, RHE has a worse debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of -1.80, we must say that RHE is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of RHE (-1.80) is worse than 82.41% of its industry peers.
- The Debt to FCF ratio of RHE is 60.13, which is on the high side as it means it would take RHE, 60.13 years of fcf income to pay off all of its debts.
- RHE has a Debt to FCF ratio (60.13) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 60.13 | ||
| Altman-Z | -1.8 |
ROIC/WACCN/A
WACC5.19%
2.3 Liquidity
- RHE has a Current Ratio of 0.29. This is a bad value and indicates that RHE is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 0.29, RHE is doing worse than 93.52% of the companies in the same industry.
- RHE has a Quick Ratio of 0.29. This is a bad value and indicates that RHE is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 0.29, RHE is doing worse than 93.52% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.29 | ||
| Quick Ratio | 0.29 |
3. RHE Growth Analysis
3.1 Past
- The earnings per share for RHE have decreased strongly by -108.34% in the last year.
- The Revenue for RHE has decreased by -24.56% in the past year. This is quite bad
- The Revenue has been decreasing by -4.88% on average over the past years.
EPS 1Y (TTM)-108.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.19%
Revenue 1Y (TTM)-24.56%
Revenue growth 3Y-0.79%
Revenue growth 5Y-4.88%
Sales Q2Q%2.05%
3.2 Future
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. RHE Valuation Analysis
4.1 Price/Earnings Ratio
- RHE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- RHE's Enterprise Value to EBITDA is on the same level as the industry average.
- 95.37% of the companies in the same industry are more expensive than RHE, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.77 | ||
| EV/EBITDA | 28.41 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. RHE Dividend Analysis
5.1 Amount
- No dividends for RHE!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
RHE Fundamentals: All Metrics, Ratios and Statistics
NYSEARCA:RHE (2/3/2025, 8:04:01 PM)
2.7741
+0.09 (+3.51%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength60.87
Industry Growth63.98
Earnings (Last)11-13 2024-11-13
Earnings (Next)03-31 2025-03-31
Inst Owners2.13%
Inst Owner Change-60.32%
Ins Owners14.05%
Ins Owner Change0%
Market Cap5.22M
Revenue(TTM)17.20M
Net Income(TTM)-2.89M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend3.45
Dividend Growth(5Y)90.1%
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.3 | ||
| P/FCF | 6.77 | ||
| P/OCF | 4.2 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 28.41 |
EPS(TTM)-1.55
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.41
FCFY14.76%
OCF(TTM)0.66
OCFY23.81%
SpS9.15
BVpS-1.27
TBVpS-3.46
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -4.81% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 49.69% | ||
| FCFM | 4.48% |
ROA(3y)10.26%
ROA(5y)3.75%
ROE(3y)6943.44%
ROE(5y)4142.66%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.29
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 60.13 | ||
| Debt/EBITDA | 25.78 | ||
| Cap/Depr | 23.41% | ||
| Cap/Sales | 2.74% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 69.15% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.29 | ||
| Quick Ratio | 0.29 | ||
| Altman-Z | -1.8 |
F-Score4
WACC5.19%
ROIC/WACCN/A
Cap/Depr(3y)19.64%
Cap/Depr(5y)15.23%
Cap/Sales(3y)2.27%
Cap/Sales(5y)1.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-108.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0.19%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-24.56%
Revenue growth 3Y-0.79%
Revenue growth 5Y-4.88%
Sales Q2Q%2.05%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y79.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y148.86%
FCF growth 3Y48.26%
FCF growth 5Y22.22%
OCF growth 1Y189.42%
OCF growth 3Y42.05%
OCF growth 5Y22.46%
REGIONAL HEALTH PROPERTIES / RHE Fundamental Analysis FAQ
What is the ChartMill fundamental rating of REGIONAL HEALTH PROPERTIES (RHE) stock?
ChartMill assigns a fundamental rating of 1 / 10 to RHE.
What is the valuation status of REGIONAL HEALTH PROPERTIES (RHE) stock?
ChartMill assigns a valuation rating of 2 / 10 to REGIONAL HEALTH PROPERTIES (RHE). This can be considered as Overvalued.
What is the profitability of RHE stock?
REGIONAL HEALTH PROPERTIES (RHE) has a profitability rating of 1 / 10.
How financially healthy is REGIONAL HEALTH PROPERTIES?
The financial health rating of REGIONAL HEALTH PROPERTIES (RHE) is 0 / 10.
Is the dividend of REGIONAL HEALTH PROPERTIES sustainable?
The dividend rating of REGIONAL HEALTH PROPERTIES (RHE) is 0 / 10 and the dividend payout ratio is 0%.